[Federal Register: June 10, 2004 (Volume 69, Number 112)]
[Notices]
[Page 32570-32573]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10jn04-102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Comprehensive Community and Home-Based Care and Support for
People Living With HIV and AIDS in India
Announcement Type: New.
Funding Opportunity Number: 04201.
Catalog of Federal Domestic Assistance Number: 93.941.
Key Dates:
Application Deadline: July 12, 2004.
I. Funding Opportunity Description
Authority: This program is authorized under section 307 of the
Public Health Service Act, [42 U.S.C. Section 2421], as amended.
Purpose: The purpose of the program is to improve the quality of
life of people living with HIV/AIDS in India and their families. With
the recent commitment by the government of India to provide
antiretroviral (ARV) treatment to a large population of people living
with HIV/AIDS, there is an urgent need to implement sustainable and
comprehensive programs for comprehensive community and home-based care
in areas of high prevalence and high risk. This is accomplished by
supporting, sustaining and expanding current activities for
comprehensive community and home-based care and support for people
living with HIV and AIDS in India.
Measurable outcomes of the program will be in alignment with the
following performance goal(s) for the National Center for HIV, STD and
TB Prevention (NCHSTP): initiate, expand or strengthen HIV/AIDS
prevention, care, treatment and support activities globally.
The measurable outcomes of the program will be in alignment with
goals of the Global AIDS Program (GAP), NCHSTP to reduce HIV
transmission and improve care of persons living with HIV.
The program will also contribute to the United States Federal
Government's goals of:
Increasing the proportion of HIV infected people who are
linked to appropriate prevention, care and treatment services.
Increasing the proportion of HIV infected persons who know
they are infected.
Decreasing the number of persons at high-risk for
acquiring or transmitting HIV infection.
Activities:
Awardee activities for this program are as follows:
Collaborate with CDC, the Government of India, the Indian
Network of Positive People, Non-Governmental Organizations (NGOs) and
other partners to ensure: (1) That there is country ownership of all
activities; (2) that proposed activities complement existing efforts
within India; and (3) that activities are supportive of indigenous
expertise and institutions.
Collaborate with CDC, the Government of India, the Indian
Network of Positive People, NGOs and other partners for the development
of capacity for the local and national level Ministries of Health, care
providers, NGOs, groups and networks of HIV positive people and other
in-country partners to deliver services.
Develop and implement community and home level
intervention programs with vulnerable populations such as youth (age
15-29 years old), women and migrant populations living in selected high
prevalence (urban and rural) areas. Intervention programs may include:
(1) Provision of voluntary counseling and testing for HIV/STD and/or
tuberculosis; (2) provision of care and treatment for HIV/STD and/or
tuberculosis; (3) Information, Education and Communication (IEC)
campaigns; and (3) behavior change for HIV infected and uninfected
persons.
Focus on the following specific activities:
1. Voluntary Counseling and Testing (VCT): implement, monitor, and
evaluate HIV counseling and testing programs. Identify barriers and
concerns
[[Page 32571]]
raised in providing VCT. Implement and coordinate, with other national
programs, to help reduce HIV-related fear, stigma, discrimination and
isolation.
2. STD prevention and care: expand and improve the diagnosis and
treatment of STDs, including risk reduction counseling and education,
as a means of reducing the continued transmission of HIV.
3. Prevention and Youth: implement youth-focused prevention/
intervention programs, testing prevention programs, secondary
prevention for HIV-positive youth, and build youth development
programs.
4. Implement HIV/AIDS care, support, and treatment, at the
community level, and in the homes of persons and their families
affected by HIV, to prevent and treat HIV and related opportunistic
infections with a special emphasis on tuberculosis.
5. Design and implement palliative care programs for persons and
their families affected by HIV.
6. Increase access to health care, build capacity, and strengthen
linkages for follow up of individuals from the health care institutions
to the community and home.
7. Increase access to psycho-social services, economic support, and
prevention services for people living with HIV/AIDS and their families.
8. Increase community support for people living with HIV/AIDS and
their families.
9. Develop and improve the capacity of local partners, Government
and private health services, NGOs, groups and networks of people living
with HIV, and other community groups to provide home-based care and
support services.
10. Participate in specific India-based workgroups that develop and
review ongoing country assistance activities. The product of these
workgroups will define the activities of the collaborating agencies.
11. Develop activities to document critical components necessary
for expansion and replication of community and home-based programs in
other areas in India.
12. Develop and implement a program for monitoring and evaluation
of all program components.
In a cooperative agreement, CDC staff is substantially involved in
the program activities, above and beyond routine grant monitoring.
CDC Activities for this program are as follows:
Collaborate with the Government of India, USAID India
mission and other partners to assist recipient in the development of
plans for program assistance based upon the needs of the selected
communities, the CDC technical assistance portfolio, and HIV prevention
activities conducted by other partners. This also includes the
development of a strategic plan for expansion of activities into other
high prevalence areas.
Provide consultations and scientific and technical
assistance based on the CDC GAP goals to promote the use of best
practices known at this time. This may include provision of technical
assistance including support from CDC staff and/or CDC/GAP partners for
designing, planning, implementing and monitoring community and home-
based care activities in selected high prevalence areas. This may also
include support for assessment visits, direct technical reviews, and
the review of existing materials available for people living with HIV;
and development of information and education resources for people
living with HIV/AIDS.
Facilitate in-country planning and review meetings for the
purpose of ensuring coordination of country-based program technical
assistance activities. CDC will act as liaison and assist in
coordinating activities as required between the applicant and other
NGOs, government of India organizations, and other CDC, GAP partners.
Technical assistance and training may be provided directly by CDC
staff or through organizations that have successfully competed for
funding under a separate CDC contract.
II. Award Information
Type of Award: Cooperative Agreement.
CDC involvement in this program is listed in the Activities Section
above.
Fiscal Year Funds: FY 2004.
Approximate Total Funding: $3,500,000. (This amount is for the
entire five-year project period.)
Approximate Number of Awards: 1.
Approximate Average Award: $700,000. (This amount is for the first
12-month budget period, and includes only direct costs).
Floor of Award Range: $600,000.
Ceiling of Award Range: $700,000.
Anticipated Award Date: September 1, 2004.
Budget Period Length: 12 months.
Project Period Length: Five years.
Throughout the project period, CDC's commitment to continuation of
awards will be conditioned on the availability of funds, evidence of
satisfactory progress by the recipient (as documented in required
reports), and the determination that continued funding is in the best
interest of the Federal government.
III. Eligibility Information
III.1. Eligible Applicants
Applications may be submitted by public and private nonprofit
organizations, and by governments and their agencies, such as:
Public nonprofit organizations.
Private nonprofit organizations.
Organizations must be based in India.
III.2. Cost Sharing or Matching
Matching funds are not required for this program.
III.3. Other
If you request a funding amount greater than the ceiling of the
award range, your application will be considered non-responsive and
will not be entered into the review process. You will be notified that
your application did not meet the submission requirements.
If your application is incomplete or non-responsive to the
requirements listed below, it will not be entered into the review
process. You will be notified that your application did not meet the
submission requirements.
Applicants must have:
1. At least five years of experience in delivering HIV, STD and/or
TB prevention and care programs in India.
2. At least three years of experience implementing programs to
deliver and monitor care and support for HIV/AIDS at both the community
and the home-based level in India. These programs must be ongoing and
established in high risk communities in high prevalence states in
India.
In December of 2003, the government of India made a landmark
commitment to collaborate with the World Health Organization in
implementing their initiative of ``Treating 3 Million People by 2005''
by providing antiretroviral treatment to a large population of people
living with HIV/AIDS in India. As a result an urgent immediate need
exists to support, expand and sustain activities for comprehensive
community and home-based care for HIV positive individuals and family
members. Starting an effective community and home-based HIV care
program from scratch, including establishing partnerships with key
partners cannot be accomplished in the limited time required. To
successfully address and meet the critical time sensitive need for
rapid scale up, an established program with demonstrated partnerships
within the HIV positive community and a proven track record must be
identified and utilized to respond to the government's initiative and
the CDC GAP.
[[Page 32572]]
IV. Application and Submission Information
IV.1. Address To Request Application Package
To apply for this funding opportunity use application form PHS
5161. Application forms and instructions are available on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and Grants Office Technical Information Management Section
(PGO-TIM) staff at: (770) 488-2700. Application forms can be mailed to
you.
IV.2. Content and Form of Submission
Application: You must submit a project narrative with your
application forms. Your narrative must be submitted in the following
format:
Maximum number of pages: 25. If your narrative exceeds the
page limit, only the first pages which are within the page limit will
be reviewed.
Double spaced.
Font size: 12 point unreduced.
Paper size: 8.5 by 11 inches.
Page margin size: One inch.
Printed only on one side of page.
Held together only by rubber bands or metal clips; not
bound in any other way.
Must be submitted in English.
Your narrative should address activities to be conducted over the
entire project period, and must include the following items in the
order listed:
Plan.
Objectives.
Activities.
Methods of Monitoring the Project.
Methods of Project Evaluation.
Summary Budget by line item along with a budget
justification (this will not be counted against the stated page limit).
Additional information may be included in the application
appendices. The appendices will not be counted toward the narrative
page limit. This additional information includes:
Organizational Chart.
Curriculum Vitae/Resumes of Current Staff.
Proposed staffing pattern (include qualifications)
required to carry out program activities.
You are required to have a Dun and Bradstreet Data Universal
Numbering System (DUNS) number to apply for a grant or cooperative
agreement from the Federal government. The DUNS number is a nine-digit
identification number, which uniquely identifies business entities.
Obtaining a DUNS number is easy and there is no charge. To obtain a
DUNS number, access http://www.dunandbradstreet.com or call 1-866-705-
5711.
For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
If your application form does not have a
DUNS number field, please write your DUNS number at the top of the
first page of your application, and/or include your DUNS number in your
application cover letter.
Additional requirements that may require you to submit additional
documentation with your application are listed in section ``VI.2
Administrative and National Policy Requirements.''
IV.3. Submission Dates and Time
Application Deadline Date: July 12, 2004.
Explanation of Deadlines: Applications must be received in the CDC
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline
date. If you send your application by the United States Postal Service
or commercial delivery service, you must ensure that the carrier will
be able to guarantee delivery of the application by the closing date
and time. If CDC receives your application after closing due to: (1)
Carrier error, when the carrier accepted the package with a guarantee
for delivery by the closing date and time, or (2) significant weather
delays or natural disasters, you will be given the opportunity to
submit documentation of the carriers guarantee. If the documentation
verifies a carrier problem, CDC will consider the application as having
been received by the deadline.
This announcement is the definitive guide on application format,
content, and deadlines. It supersedes information provided in the
application instructions. If your application does not meet the
deadline above, it will not be eligible for review, and will be
discarded. You will be notified that your application did not meet the
submission requirements.
CDC will not notify you upon receipt of your application. If you
have a question about the receipt of your application, first contact
your courier. If you still have a question, contact the PGO-TIM staff
at: (770) 488-2700. Before calling, please wait two to three days after
the application deadline. This will allow time for applications to be
processed and logged.
IV.4. Intergovernmental Review of Applications
Executive Order 12372 does not apply to this program.
IV.5. Funding Restrictions
Funding restrictions, which must be taken into account while
writing your budget are as follows:
Antiretroviral Drugs--The purchase of antiretrovirals,
reagents, and laboratory equipment for antiretroviral treatment
projects require pre-approval from the GAP headquarters.
Needle Exchange--No funds appropriated under this Act
shall be used to carry out any program of distributing sterile needles
or syringes for the hypodermic injection of any illegal drug.
Funds may be spent for reasonable program purposes,
including personnel, training, travel, supplies and services. Equipment
may be purchased if deemed necessary to accomplish program objectives;
however, prior written approval by CDC officials must be requested in
writing.
All requests for funds contained in the budget shall be
stated in U.S. dollars. Once an award is made, CDC will not compensate
foreign grantees for currency exchange fluctuations through the
issuance of supplemental awards.
The costs that are generally allowable in grants to
domestic organizations are allowable to foreign institutions and
international organizations, with the following exception: With the
exception of the American University, Beirut, and the World Health
Organization, Indirect Costs will not be paid (either directly or
through sub-award) to organizations located outside the territorial
limits of the United States or to international organization regardless
of their location.
The applicant may contract with other organizations under
this program; however the applicant must perform a substantial portion
of the activities (including program management and operations, and
delivery of prevention and care services for which funds are required).
You must obtain an annual audit of these CDC funds
(program-specific audit) by a U.S.-based audit firm with international
branches and current licensure/authority in-country, and in accordance
with International Accounting Standards or equivalent standard(s)
approved in writing by CDC.
A fiscal Recipient Capability Assessment may be required,
prior to or post award, in order to review the applicant's business
management and fiscal capabilities regarding the handling of U.S.
Federal funds.
[[Page 32573]]
Guidance for completing your budget can be found on the CDC Web
site, at the following Internet address: http://www.cdc.gov/od/pgo/funding/budgetguide.htm
.
Awards will not allow reimbursement of pre-award costs.
IV.6. Other Submission Requirements
Application Submission Address: Submit the original and two hard
copies of your application by mail or express delivery service to:
Technical Information Management--PA 04201, CDC Procurement
and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
Applications may not be submitted electronically at this time.
V. Application Review Information
V.1. Criteria
You are required to provide measures of effectiveness that will
demonstrate the accomplishment of the various identified objectives of
the cooperative agreement. Measures of effectiveness must relate to the
performance goals stated in the ``Purpose'' section of this
announcement. Measures must be objective and quantitative, and must
measure the intended outcome. These measures of effectiveness must be
submitted with the application and will be an element of evaluation.
Your application will be evaluated against the following criteria:
1. Ability to carry Out the Project (25 points)
Does the applicant provide documents, which demonstrate the
organization's capability to achieve the purpose of the project?
2. Technical Approach (20 points)
Does the applicant's proposal include an overall design strategy,
including measurable time lines? Does the proposal address regular
monitoring and evaluation, and the potential effectiveness of the
proposed activities in meeting objectives?
3. Understanding of the Problem (20 points)
Does the applicant demonstrate a clear and concise understanding of
the nature of the problem described in the Purpose section of this
announcement? Does the applicant include a description of the public
health importance of the planned activities to be undertaken and
realistic presentation of proposed objectives and projects?
4. Personnel (20 points)
Are professional personnel involved in this project qualified? Does
the applicant include evidence of experience in working with HIV/AIDS,
opportunistic infections, and HIV/STD surveillance?
5. Plans for Administration and Management of Projects (15 points)
Are plans for administering the projects adequate?
6. Budget (not scored)
Is the itemized budget for conducting the project, along with
justification, reasonable and consistent with stated objectives and
planned program activities?
V.2. Review and Selection Process
Applications will be reviewed for completeness by the Procurement
and Grants Office (PGO) staff, and for responsiveness by NCHSTP/GAP.
Incomplete applications and applications that are non-responsive to the
eligibility criteria will not advance through the review process.
Applicants will be notified that their application did not meet
submission requirements.
An objective review panel will evaluate complete and responsive
applications according to the criteria listed in the ``V.1. Criteria''
section above.
V.3. Anticipated Announcement and Award Dates
September 1, 2004.
VI. Award Administration Information
VI.1. Award Notices
Successful applicants will receive a Notice of Grant Award (NGA)
from the CDC Procurement and Grants Office. The NGA shall be the only
binding, authorizing document between the recipient and CDC. The NGA
will be signed by an authorized Grants Management Officer, and mailed
to the recipient fiscal officer identified in the application.
Unsuccessful applicants will receive notification of the results of
the application review by mail.
VI.2. Administrative and National Policy Requirements
45 CFR Part 74 and Part 92
For more information on the Code of Federal Regulations, see the
National Archives and Records Administration at the following Internet
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
The following additional requirements apply to this project:
AR-6 Patient Care
AR-10 Smoke-Free Workplace Requirements
Additional information on these requirements can be found on the
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm
.
VI.3. Reporting Requirements
You must provide CDC with an original, plus two copies of the
following reports in English:
1. Interim progress report, no less than 90 days before the end of
the budget period. The progress report will serve as your non-competing
continuation application, and must contain the following elements:
a. Current Budget Period Activities Objectives.
b. Current Budget Period Financial Progress.
c. New Budget Period Program Proposed Activity Objectives.
d. Budget.
e. Additional Requested Information.
f. Measures of Effectiveness
2. Financial status report no more than 90 days after the end of
the budget period.
3. Final financial and performance reports, no more than 90 days
after the end of the project period.
These reports must be mailed to the Grants Management Specialist
listed in the ``Agency Contacts'' section of this announcement.
VII. Agency Contacts
For general questions about this announcement, contact: Technical
Information Management Section, CDC Procurement and Grants Office, 2920
Brandywine Road, Atlanta, GA 30341, Telephone: (770) 488-2700.
For program technical assistance, contact: Jeanine Ambrosio,
Project Officer, Centers for Disease Control and Prevention, NCHSTP/
GAP, 1 Corporate Square, Atlanta, GA 30329, Telephone: (404) 639-6340,
e-mail: JAmbrosio@cdc.gov.
For budget assistance, contact: Shirley Wynn, Grants Management
Specialist, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341, Telephone: (770) 488-1515, e-mail: SWynn@cdc.gov.
Dated: June 4, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease
Control and Prevention.
[FR Doc. 04-13139 Filed 6-9-04; 8:45 am]
BILLING CODE 4163-18-P